{
    "AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance": "11437503",
    "Cross-reactive sarbecovirus antibodies induced by mosaic RBD-nanoparticles": "11722225",
    "Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic": "11599457",
    "Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate": "11630572",
    "Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion": "10938001",
    "Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations": "11289243",
    "Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1": "11754117",
    "Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain": "11601353",
    "Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain": "11406931",
    "Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3": "11461813",
    "Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions": "11562025",
    "Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants": "11430188",
    "Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity": "11722104",
    "Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages": "11407393",
    "Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development": "11609190",
    "Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike Protein": "11661143",
    "Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants": "11374805",
    "Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1": "11554226"
}